Concepts (87)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Nephritis, Interstitial | 2 | 2023 | 40 | 1.520 |
Why?
|
| Renal Insufficiency, Chronic | 4 | 2024 | 845 | 1.410 |
Why?
|
| Diabetic Nephropathies | 1 | 2024 | 115 | 0.780 |
Why?
|
| Electrolytes | 1 | 2022 | 58 | 0.760 |
Why?
|
| Renal Insufficiency | 1 | 2022 | 256 | 0.630 |
Why?
|
| Kidney Diseases | 1 | 2022 | 489 | 0.550 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2024 | 1410 | 0.410 |
Why?
|
| Ceramides | 1 | 2013 | 46 | 0.410 |
Why?
|
| Agrochemicals | 2 | 2023 | 13 | 0.400 |
Why?
|
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2013 | 91 | 0.370 |
Why?
|
| Kidney | 2 | 2023 | 1330 | 0.230 |
Why?
|
| Hyperinsulinism | 1 | 2024 | 62 | 0.210 |
Why?
|
| Glucagon-Like Peptide 1 | 1 | 2024 | 74 | 0.210 |
Why?
|
| Paraquat | 1 | 2022 | 14 | 0.190 |
Why?
|
| Cations | 1 | 2022 | 37 | 0.190 |
Why?
|
| Protein Sorting Signals | 1 | 2022 | 41 | 0.180 |
Why?
|
| Low Density Lipoprotein Receptor-Related Protein-2 | 1 | 2022 | 16 | 0.180 |
Why?
|
| Receptor, IGF Type 1 | 1 | 2022 | 95 | 0.180 |
Why?
|
| Receptors, Immunologic | 1 | 2022 | 126 | 0.180 |
Why?
|
| Mice | 6 | 2023 | 18461 | 0.170 |
Why?
|
| Sirtuin 3 | 1 | 2021 | 30 | 0.170 |
Why?
|
| Peritoneal Dialysis | 1 | 2023 | 137 | 0.170 |
Why?
|
| Reperfusion Injury | 1 | 2021 | 110 | 0.160 |
Why?
|
| Urokinase-Type Plasminogen Activator | 1 | 2020 | 38 | 0.160 |
Why?
|
| Receptors, Urokinase Plasminogen Activator | 1 | 2020 | 25 | 0.160 |
Why?
|
| Hypoglycemic Agents | 1 | 2024 | 482 | 0.160 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2024 | 1246 | 0.150 |
Why?
|
| Cardiomyopathies | 1 | 2022 | 510 | 0.130 |
Why?
|
| Coronary Angiography | 1 | 2020 | 485 | 0.130 |
Why?
|
| Mitochondria | 3 | 2022 | 747 | 0.130 |
Why?
|
| Animals | 6 | 2023 | 34785 | 0.130 |
Why?
|
| Renal Dialysis | 1 | 2024 | 948 | 0.130 |
Why?
|
| Serine Endopeptidases | 1 | 2017 | 188 | 0.120 |
Why?
|
| Reactive Oxygen Species | 2 | 2021 | 516 | 0.120 |
Why?
|
| Virulence Factors | 1 | 2017 | 187 | 0.120 |
Why?
|
| Streptococcus pneumoniae | 1 | 2017 | 381 | 0.110 |
Why?
|
| Sphingosine | 1 | 2013 | 16 | 0.100 |
Why?
|
| DNA Fragmentation | 1 | 2013 | 57 | 0.100 |
Why?
|
| Cross-Sectional Studies | 1 | 2022 | 3760 | 0.100 |
Why?
|
| Sphingolipids | 1 | 2013 | 34 | 0.100 |
Why?
|
| Culture Media | 1 | 2013 | 183 | 0.100 |
Why?
|
| Mice, Inbred C57BL | 1 | 2022 | 4752 | 0.100 |
Why?
|
| Humans | 8 | 2024 | 131934 | 0.100 |
Why?
|
| Acute Kidney Injury | 1 | 2020 | 672 | 0.100 |
Why?
|
| Bacterial Proteins | 1 | 2017 | 930 | 0.090 |
Why?
|
| Breast Neoplasms | 1 | 2024 | 2645 | 0.090 |
Why?
|
| Fatty Acids | 1 | 2013 | 356 | 0.090 |
Why?
|
| Cardiac Surgical Procedures | 1 | 2020 | 1173 | 0.090 |
Why?
|
| Female | 5 | 2024 | 70592 | 0.080 |
Why?
|
| Autophagy | 1 | 2013 | 426 | 0.080 |
Why?
|
| Male | 4 | 2023 | 64877 | 0.080 |
Why?
|
| Risk Factors | 1 | 2023 | 10935 | 0.070 |
Why?
|
| Child | 2 | 2023 | 25761 | 0.060 |
Why?
|
| Cell Line, Tumor | 1 | 2013 | 3678 | 0.060 |
Why?
|
| Retrospective Studies | 1 | 2024 | 17375 | 0.060 |
Why?
|
| Antineoplastic Agents | 1 | 2013 | 1825 | 0.050 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2024 | 82 | 0.050 |
Why?
|
| Cryoelectron Microscopy | 1 | 2024 | 243 | 0.050 |
Why?
|
| Leucine | 1 | 2022 | 260 | 0.040 |
Why?
|
| Superoxides | 1 | 2021 | 133 | 0.040 |
Why?
|
| Fibrosis | 1 | 2022 | 421 | 0.040 |
Why?
|
| Kidney Tubules | 1 | 2020 | 74 | 0.040 |
Why?
|
| Glycoproteins | 1 | 2022 | 375 | 0.040 |
Why?
|
| Podocytes | 1 | 2020 | 77 | 0.040 |
Why?
|
| HEK293 Cells | 1 | 2022 | 799 | 0.040 |
Why?
|
| Sex Characteristics | 1 | 2021 | 327 | 0.040 |
Why?
|
| Estradiol | 1 | 2021 | 487 | 0.040 |
Why?
|
| DNA | 1 | 2024 | 1473 | 0.040 |
Why?
|
| Insulin | 1 | 2022 | 1168 | 0.030 |
Why?
|
| Myocytes, Cardiac | 1 | 2022 | 660 | 0.030 |
Why?
|
| Catalysis | 1 | 2017 | 139 | 0.030 |
Why?
|
| Amino Acid Motifs | 1 | 2017 | 206 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2020 | 1254 | 0.030 |
Why?
|
| Intensive Care Units | 1 | 2020 | 523 | 0.030 |
Why?
|
| Protein Domains | 1 | 2017 | 260 | 0.030 |
Why?
|
| Testosterone | 1 | 2021 | 611 | 0.030 |
Why?
|
| Critical Illness | 1 | 2020 | 618 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 2444 | 0.030 |
Why?
|
| Mice, Knockout | 1 | 2022 | 3860 | 0.030 |
Why?
|
| Antibodies, Monoclonal | 1 | 2020 | 1028 | 0.030 |
Why?
|
| Risk Assessment | 1 | 2020 | 3733 | 0.020 |
Why?
|
| Biomarkers | 1 | 2020 | 3405 | 0.020 |
Why?
|
| Disease Models, Animal | 1 | 2020 | 4682 | 0.020 |
Why?
|
| Postoperative Complications | 1 | 2020 | 3139 | 0.020 |
Why?
|
| Adult | 1 | 2023 | 31538 | 0.010 |
Why?
|
| Aged | 1 | 2020 | 21390 | 0.010 |
Why?
|
| Middle Aged | 1 | 2020 | 28947 | 0.010 |
Why?
|